These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31424267)

  • 1. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.
    Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J
    DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
    Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
    Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
    Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
    Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer.
    Hergueta-Redondo M; Sarrio D; Molina-Crespo Á; Vicario R; Bernadó-Morales C; Martínez L; Rojo-Sebastián A; Serra-Musach J; Mota A; Martínez-Ramírez Á; Castilla MÁ; González-Martin A; Pernas S; Cano A; Cortes J; Nuciforo PG; Peg V; Palacios J; Pujana MÁ; Arribas J; Moreno-Bueno G
    Oncotarget; 2016 Aug; 7(35):56295-56308. PubMed ID: 27462779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
    Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype.
    Lee K; Jang MH; Chung YR; Lee Y; Kang E; Kim SW; Kim YJ; Kim JH; Kim IA; Park SY
    Hum Pathol; 2017 Mar; 61():111-120. PubMed ID: 27989787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of the value of RAB family genes in prognosis of breast invasive carcinoma.
    Lin S; Cao C; Meng Y; Wu P; Gao P; Zhi W; Peng T; Wu P; Gui L
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32432324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes.
    Han B; Zhang H; Zhu Y; Han X; Wang Z; Gao Z; Yuan Y; Tian R; Zhang F; Niu R
    Aging (Albany NY); 2020 Jul; 12(13):13318-13337. PubMed ID: 32649310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer.
    Han B; Zhen F; Zheng XS; Hu J; Chen XS
    BMC Cancer; 2022 Mar; 22(1):297. PubMed ID: 35313846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer.
    Shi W; Xu C; Lei P; Sun X; Song M; Guo Y; Song W; Li Y; Yu L; Zhang H; Wang H; Zhang DL
    Breast Cancer Res Treat; 2024 Sep; 207(2):417-434. PubMed ID: 38834774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-1 Expression as a Prognosticator Marker of Survival in Breast Cancer Patients.
    Zhang X; Cui Y; He M; Jiao Y; Yang Z
    Breast Care (Basel); 2020 Jun; 15(3):272-280. PubMed ID: 32774222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.
    Guo J; Du X; Li C
    Biomed Res Int; 2022; 2022():4434887. PubMed ID: 35535040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
    BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
    Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
    Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
    Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
    Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomics and Prognosis Analysis to Identify Critical Biomarkers in Invasive Breast Carcinoma.
    Wu J; Liu XJ; Hu JN; Liao XH; Lin FF
    Technol Cancer Res Treat; 2020; 19():1533033820957011. PubMed ID: 33176622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.